收稿日期: 2024-01-24
录用日期: 2024-06-24
网络出版日期: 2024-11-28
A case report of atypical anti-glomerular basement membrane disease with membrane hyperplasia lesions
Received date: 2024-01-24
Accepted date: 2024-06-24
Online published: 2024-11-28
非典型抗肾小球基底膜(glomerular basement membrane,GBM)肾炎罕见,伴有膜增生病变的更为少见,目前对其治疗方案尚未明确。该文报道1例抗GBM抗体阴性,但肾组织活检提示“肾小球膜增生病变伴IgG线样阳性”的非典型抗GBM肾炎病例。该患者以大量蛋白尿、血尿、水肿、肾功能损伤为主要特征,排除继发因素后经肾组织活检诊断为“非典型抗GBM肾炎”。给予糖皮质激素联合环磷酰胺治疗后,患者出现肺部感染及急性左心衰竭,转院行规律血液透析治疗。后期发展至终末期肾脏病阶段,继续接受规律血液透析治疗。
关键词: 非典型抗肾小球基底膜肾炎; 膜增生性病变; 肾病综合征
张昕萍 , 王自闯 , 陈小永 . 伴膜增生病变的非典型抗肾小球基底膜肾炎1例报道[J]. 上海交通大学学报(医学版), 2024 , 44(11) : 1472 -1476 . DOI: 10.3969/j.issn.1674-8115.2024.11.016
Atypical anti-glomerular basement membrane (GBM) disease is rare, and the atypical anti-GBM disease with membrane hyperplasia lesion is even rarer. The treatment plan for it is not clear. This article reports a case of atypical anti-GBM disease with a negative anti-GBM antibody test, but renal tissue biopsy showed “glomerular membrane hyperplasia lesions with positive IgG linearity”, which provides a reference for clinical diagnosis and treatment. The patient exhibited massive proteinuria, hematuria, edema, and renal impairment. After ruling out secondary factors, the patient was diagnosed with “atypical anti-GBM nephritis” by renal tissue biopsy, and was treated with glucocorticoids combined with cyclophosphamide, after which the patient developed a lung infection and acute left heart failure, and received regular hemodialysis treatment. Then the patient progressed to the stage of end-stage renal disease and continued to receive regular hemodialysis treatment.
1 | LAZOR R, BIGAY-GAME L, COTTIN V, et al. Groupe d′Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERMOP) and the Swiss Group for Interstitial and Orphan Lung Diseases (SIOLD). Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases[J]. Medicine (Baltimore), 2007, 86(3): 181-193. |
2 | ISOBE S, TOMOSUGI T, FUTAMURA K, et al. A case of recurrent atypical anti-glomerular basement membrane nephritis suspicion after renal transplantation[J]. Nephron, 2020, 144(Suppl 1): 49-53. |
3 | 赵明辉, 丁焦生, 刘玉春, 等. 41例抗肾小球基底膜抗体相关疾病的临床和病理分析[J]. 中华内科杂志, 2001, 40(5): 316-317. |
3 | ZHAO M H, DING J S, LIU Y C, et al. A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases[J]. Chinese Journal of Internal Medicine,2001, 40(5): 316-317. |
4 | BECK L H, AYOUB I, CASTER D, et al. KDOQI US commentary on the 2021 KDIGO clinical practice guideline for the management of glomerular diseases[J]. Am J Kidney Dis, 2023, 82(2): 121-175. |
5 | NASR S H, COLLINS A B, ALEXANDER M P, et al. The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis[J]. Kidney Int, 2016, 89(4): 897-908. |
6 | ROSALES I A, COLVIN R B. Glomerular disease with idiopathic linear immunoglobulin deposition: a rose by any other name would be atypical[J]. Kidney Int, 2016, 89(4): 750-752. |
7 | CHAUVEAU B, GIBIER J B, OLAGNE J, et al. Atypical anti-glomerular basement membrane nephritis: a case series from the French nephropathology group[J]. Am J Kidney Dis, 2024, 83(6): 713-728.e1. |
8 | SHEN C R, JIA X Y, CUI Z, et al. Clinical-pathological features and outcome of atypical anti-glomerular basement membrane disease in a large single cohort[J]. Front Immunol, 2020, 11: 2035. |
9 | CORNELL L D. Anti-glomerular basement membrane disease: broadening the spectrum[J]. Am J Kidney Dis, 2024, 83(6): 701-703. |
10 | 黎煜妍, 陶密, 何一晴, 等. 非典型抗肾小球基底膜病1例并文献复习[J]. 临床肾脏病杂志, 2023, 23(9): 779-782. |
10 | LI Y Y, TAO M, HE Y Q, et al. Atypical anti-glomerular basement membrane disease: one case report with a literature review[J]. Journal of Clinical Nephrology, 2023, 23(9): 779-782. |
11 | OLIVIER M, WATSON H, LEE D, et al. Monotypic IgG1-kappa atypical anti-glomerular basement membrane nephritis: a case report[J]. Case Rep Nephrol Dial, 2019, 9(1): 8-14. |
12 | KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) GLOMERULAR DISEASES WORK GROUP. KDIGO 2021 clinical practice guideline for the management of glomerular diseases[J]. Kidney Int, 2021, 100(4s): S1-S276. |
/
〈 |
|
〉 |